iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
102 hedge funds and large institutions have $115M invested in iShares Genomics Immunology and Healthcare ETF in 2021 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 22 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
102
Holders Change
+14
Holders Change %
+15.91%
% of All Funds
1.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
33
Reduced
22
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Jane Street
New York
|
$6.54M |
| 2 |
2
Morgan Stanley
New York
|
$8.12M |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$13.5M |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$3.66M |
| 5 |
AWM
5
Apollon Wealth Management
Mount Pleasant,
South Carolina
|
$2.05M |
